Bank of America
ENZ

Bank of America’s Enzo Biochem, Inc. ENZ Stock Holding History

Bank of America’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-3,962
Closed -$1.47K – 8781
2025
Q1 		$1.47K Buy
3,962
+1,747
+79% +$965 ﹤0.01% 7375
2024
Q4 		$1.58K Buy
2,215
+2
+0.1% +$2 ﹤0.01% 7227
2024
Q3 		$2.48K Sell
2,213
-1
-0% -$1 ﹤0.01% 7098
2024
Q2 		$2.41K Sell
2,214
-174
-7% -$196 ﹤0.01% 7115
2024
Q1 		$3.03K Sell
2,388
-724
-23% -$956 ﹤0.01% 7069
2023
Q4 		$4.33K Buy
3,112
+24
+0.8% +$32 ﹤0.01% 7034
2023
Q3 		$4.32K Hold
3,088
– – ﹤0.01% 7026
2023
Q2 		$5.68K Hold
3,088
– – ﹤0.01% 6962
2023
Q1 		$7.5K Sell
3,088
-43
-1% -$64 ﹤0.01% 6984
2022
Q4 		$4.48K Sell
3,131
-2,898
-48% -$5.65K ﹤0.01% 7076
2022
Q3 		$13K Hold
6,029
– – ﹤0.01% 7173
2022
Q2 		$12K Hold
6,029
– – ﹤0.01% 7348
2022
Q1 		$17K Sell
6,029
-1,017
-14% -$3.27K ﹤0.01% 7586
2021
Q4 		$23K Sell
7,046
-18,650
-73% -$63.6K ﹤0.01% 7477
2021
Q3 		$91K Sell
25,696
-24,372
-49% -$81.3K ﹤0.01% 6772
2021
Q2 		$159K Sell
50,068
-794
-2% -$2.5K ﹤0.01% 6241
2021
Q1 		$174K Buy
50,862
+36,859
+263% +$115K ﹤0.01% 6122
2020
Q4 		$35K Buy
14,003
+11,182
+396% +$24.4K ﹤0.01% 6451
2020
Q3 		$6K Sell
2,821
-5,034
-64% -$12K ﹤0.01% 6562
2020
Q2 		$17K Buy
7,855
+6,704
+582% +$17.2K ﹤0.01% 6311
2020
Q1 		$3K Sell
1,151
-21,979
-95% -$54K ﹤0.01% 6593
2019
Q4 		$60K Sell
23,130
-795
-3% -$2.38K ﹤0.01% 6200
2019
Q3 		$87K Buy
23,925
+6,273
+36% +$22.2K ﹤0.01% 6111
2019
Q2 		$59K Sell
17,652
-33,419
-65% -$118K ﹤0.01% 6235
2019
Q1 		$139K Sell
51,071
-16,840
-25% -$55.1K ﹤0.01% 5702
2018
Q4 		$188K Buy
67,911
+40,929
+152% +$134K ﹤0.01% 5557
2018
Q3 		$111K Buy
26,982
+2,997
+12% +$13.6K ﹤0.01% 5826
2018
Q2 		$125K Sell
23,985
-3,333
-12% -$20.3K ﹤0.01% 5673
2018
Q1 		$150K Sell
27,318
-5,232
-16% -$36.9K ﹤0.01% 5529
2017
Q4 		$265K Sell
32,550
-17,893
-35% -$171K ﹤0.01% 5281
2017
Q3 		$528K Buy
50,443
+7,918
+19% +$87.9K ﹤0.01% 4914
2017
Q2 		$469K Buy
42,525
+13,940
+49% +$130K ﹤0.01% 4918
2017
Q1 		$239K Buy
28,585
+17,118
+149% +$121K ﹤0.01% 5239
2016
Q4 		$80K Buy
11,467
+2,989
+35% +$19.1K ﹤0.01% 5727
2016
Q3 		$43K Buy
8,478
+1,699
+25% +$10.1K ﹤0.01% 5786
2016
Q2 		$40K Sell
6,779
-7,051
-51% -$39.1K ﹤0.01% 5929
2016
Q1 		$62K Sell
13,830
-178
-1% -$792 ﹤0.01% 5696
2015
Q4 		$63K Hold
14,008
– – ﹤0.01% 5941
2015
Q3 		$45K Sell
14,008
-944
-6% -$2.86K ﹤0.01% 5986
2015
Q2 		$46K Buy
14,952
+849
+6% +$2.39K ﹤0.01% 5980
2015
Q1 		$42K Sell
14,103
-2,305
-14% -$7.55K ﹤0.01% 5745
2014
Q4 		$73K Buy
16,408
+7,706
+89% +$36.7K ﹤0.01% 6109
2014
Q3 		$45K Sell
8,702
-23,133
-73% -$123K ﹤0.01% 6574
2014
Q2 		$167K Buy
31,835
+31,098
+4,220% +$134K ﹤0.01% 5713
2014
Q1 		$3K Sell
737
-532
-42% -$1.82K ﹤0.01% 7479
2013
Q4 		$4K Sell
1,269
-7,341
-85% -$18.2K ﹤0.01% 7532
2013
Q3 		$22K Sell
8,610
-2,137
-20% -$5.07K ﹤0.01% 6852
2013
Q2 		$23K Buy
+10,747
New +$23.7K ﹤0.01% 6912

Other funds holding ENZ

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return

Bank of America's ENZ Position: Q2 2025 in Review

Bank of America sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 3,962 shares — an estimated $1.47K sold.

Bank of America first reported a position in ENZ in Q2 2013 and held it in 48 quarters. The position peaked at $528K in Q3 2017. 6 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.

  • Bank of America reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
  • Bank of America sold 3,962 Enzo Biochem, Inc. shares in Q2 2025, an estimated $1.47K.
  • Bank of America first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 48 quarters.
  • Bank of America's Enzo Biochem, Inc. position peaked at $528K in Q3 2017.
  • 6 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.

Based on Bank of America's 13F filing for Q2 2025, filed 14 Aug 2025.